Fentanyl News and Research

RSS

Fentanyl is a powerful synthetic opiate analgesic similar to but more potent than morphine. It is typically used to treat patients with severe pain, or to manage pain after surgery. It is also sometimes used to treat people with chronic pain who are physically tolerant to opiates. It is a schedule II prescription drug.

Deadly drug overdose rates among Black people more than doubles in Kentucky

The rate of deadly drug overdoses among Black people in Kentucky more than doubled from 2016 to 2020, according to a new analysis by University of Kentucky researchers.

1 Jun 2022

MGH scientists develop a data-driven simulation model to address the rampant opioid crisis

A data-driven simulation model designed to help policymakers to better understand and address the nation's rampant opioid crisis has been developed by a team of scientists at Massachusetts General Hospital.

31 May 2022

Study uses critical race theory to examine disparities in treating opioid use disorder

Opioid use disorder is an addiction crisis in the United States that has become increasingly lethal during the COVID-19 pandemic.

29 May 2022

The Blackfeet nation’s plight underscores the fentanyl crisis on reservations

As the pandemic was setting in during summer 2020, Justin Lee Littledog called his mom to tell her he was moving from Texas back home to the Blackfeet Indian Reservation in Montana with his girlfriend, stepson, and son.

25 May 2022

Cannabis users need higher levels of sedation during gastric endoscopies

Patients who use cannabis required higher levels of sedation during gastric endoscopies than non-users, according to research to be presented at Digestive Disease Week 2022.

23 May 2022

The new MADD movement: Parents rise up against drug deaths

Life as he knew it ended for Matt Capelouto two days before Christmas in 2019, when he found his 20-year-old daughter, Alexandra, dead in her childhood bedroom in Temecula, California. Rage overtook grief when authorities ruled her death an accident.

23 May 2022

Quality of drug supply declined in Vancouver during the COVID-19 pandemic, study finds

More than a third of people who use drugs in Vancouver, Canada reported a decline in the quality of drugs during the COVID-19 pandemic, according to a new study published in the journal Drug and Alcohol Dependence.

11 May 2022

Lifesaving drug for opioid use disorder underutilized

Researchers at Washington University School of Medicine in St. Louis and Saint Louis University found that less than half of Americans who received treatment for opioid use disorder over a five-year period were offered a potentially lifesaving medication.

10 May 2022

Rigaku Announces Narcotics Interdiction Partnership Program to Help Reduce Deaths by Overdose

Rigaku Analytical Devices, a U.S.-based pioneer of handheld 1064 nm-Raman based spectrometers, is pleased to announce its new Human Infrastructure Health & Awareness (HIHA) Technology Narcotics Identification Partnership Program.

From Rigaku Analytical Devices 10 May 2022

Study shows how a non-opioid approach successfully manages women's pain after C-section

For years, women recovering from cesarean section (C-section) deliveries have been given devices that let them, with a button, control the flow of opioid painkillers into their IV line. But as researchers and policymakers push to curb the use of opioids, clinicians are developing new strategies for treating pain after C-sections.

3 May 2022

Metrohm USA celebrates 10th annual young chemist award winner

Metrohm USA is pleased to announce the winner of its 2022 Young Chemist Award, Colby Ott. Colby is a Ph.D. candidate at West Virginia University's Forensic and Investigative Science Department in Morgantown, West Virginia, where his research centers around developing novel methods for screening seized drugs.

From Metrohm USA Inc. 20 Apr 2022

UK experts share their work in the field of opioid use disorder research at 2022 Rx Summit

University of Kentucky experts on the front lines of the nation's opioid and addiction crises will share their work in the field of opioid use disorder research, treatment and prevention this week at the 2022 Rx Drug Abuse & Heroin Summit in Atlanta April 18-22.

19 Apr 2022

$11M for North Carolina work-based rehab raises concerns

An addiction treatment facility, highly regarded by North Carolina lawmakers, sits in a residential neighborhood here and operates like a village in itself.

6 Apr 2022

CBD and THC may be safe for use with opioid pain relievers, animal study suggests

Findings from a new animal study suggest that cannabidiol (CBD) and tetrahydrocannabinol (THC) might be safe for use with opioid pain relievers.

4 Apr 2022

Calls to overhaul methadone distribution intensify, but clinics resist

Days typically start early for patients undergoing opioid addiction treatment at Denver Recovery Group's six methadone clinics in Colorado.

3 Mar 2022

Drug overdose death rates among Black Americans surpass that of whites for first time in 20 years

In 2020, the first year of the COVID-19 pandemic, the rate of drug overdose deaths among Black Americans surpassed that of whites for the first time since 1999 -; a sharp reversal of the situation a decade earlier, when rates were twice as high for whites as for Blacks, new UCLA research shows.

2 Mar 2022

Outpatient antibiotic treatment for infective endocarditis improves outcomes, reduces costs

A new modeling study suggests that when patients who inject opioids continue an antibiotic treatment for infective endocarditis outside of the hospital, they experienced better long-term health outcomes than patients who receive the standard four to six weeks of inpatient, intravenous antibiotic therapy.

28 Feb 2022

Fentanyl News and Research

Further Reading